SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-21-013626
Filing Date
2021-06-04
Accepted
2021-06-04 16:05:53
Documents
6

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 469198
2 ex4-4.htm EX-4.4 399827
3 ex4-5.htm EX-4.5 428544
4 ex5-1.htm EX-5.1 44296
5 ex23-1.htm EX-23.1 4672
6 logo_001.jpg GRAPHIC 9749
  Complete submission text file 0001493152-21-013626.txt   1361340
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-256790 | Film No.: 21996482
SIC: 7389 Services-Business Services, NEC